The protective effects of high-education levels on cognition in different stages of multiple sclerosis

Imagem de Miniatura
Arquivos
art_RIMKUS_The_protective_effects_of_higheducation_levels_on_cognition_2018.PDF (452.64 KB)
Citações na Scopus
27
Tipo de produção
article
Data de publicação
2018
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCI LTD
Autores
AVOLIO, Isabella Maria Bello
Citação
MULTIPLE SCLEROSIS AND RELATED DISORDERS, v.22, p.41-48, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Low-education attainment is associated with worse cognitive performance in multiple sclerosis (MS) patients, and possibly with a lower cognitive reserve and/or increased inflammatory activity. Cognitive reserve refers to the capability of a source of intellectual enrichment in attenuating a negative effect of a diseaserelated factor; while the inflammatory activity is often related to T2-lesion load (T2-LL) increase. Objective: To disentangle the effects of cognitive reserve and an increased T2-LL in MS-patients with low-education levels. Methods: The study included 136 MS patients and 65 healthy-controls, divided in low-education (12 years or less of school education without obtaining any technical superior degree) and high-education (more than 12 years of school education with technical or superior degree) groups. An extensive battery of neuropsychological tests was applied examining intelligence quotient and six cognitive domains. Test results were z-scored and subjects with z-scores <= -1.5 in two or more domains were considered cognitively impaired. To test the factors associated with worse cognitive performance, regression models were applied using average cognition as target; education level, Expanded Disability Status Scale (EDSS), T2-LL, disease duration, age of disease onset, age and gender as predictors. We also tested the correlation between T2-LL and cognition in the groups. To investigate the role of education level as a source of intellectual enrichment/cognitive reserve in different stages of MS, we sub-divided the MS patients in three groups according to the disease duration (less than 5 years, between 5 and 10 years and more than 10 years). Results: Worse average cognition was associated with low-education level, higher T2-LL and male gender. A higher frequency of cognitively impaired patients was observed in MS patients with low-education level, in all stages of the disease. In patients with a disease duration shorter than five years, there was a lower correlation between worse average cognition and T2-LL in the high-education level group, compared to the patients with low-education level; in MS patients with longer disease duration, we observed a stronger correlation between lesion burden and cognitive impairment in both groups. Conclusion: Education attainment is a source of intellectual enrichment and can enhance the cognitive reserve in MS patients. The protective effect of a high-education level was stronger in patients with less than five years of disease, suggesting a stronger role of cognitive reserve in short-term disease. In long-term disease we observed a greater impact of increased inflammatory activity on cognition.
Palavras-chave
Multiple sclerosis, Cognition, Education, Cognitive reserve, Demyelinating diseases, Neuropsychology
URI
https://observatorio.fm.usp.br/handle/OPI/26918
Referências
  1. Almeida L, 2012, INT J ENV RES PUB HE, V9, P2520, DOI 10.3390/ijerph9072520
  2. Benedict RHB, 2010, J INT NEUROPSYCH SOC, V16, P829, DOI 10.1017/S1355617710000688
  3. Benedict RH., 1997, BRIEF VISUOSPATIAL M
  4. Bjornevik K, 2016, MULT SCLER J, V22, P104, DOI 10.1177/1352458515579444
  5. Boylan JM, 2013, PSYCHOSOM MED, V75, P566, DOI 10.1097/PSY.0b013e31829683bd
  6. Brandt J., 2001, HOPKINS VERBAL LEARN
  7. Bruce JM, 2010, J BEHAV MED, V33, P219, DOI 10.1007/s10865-010-9247-y
  8. Butler SM, 1996, J AM GERIATR SOC, V44, P675, DOI 10.1111/j.1532-5415.1996.tb01831.x
  9. Calabrese M, 2015, MULT SCLER J, V21, P580, DOI 10.1177/1352458514542363
  10. Christensen H, 1997, INT J GERIATR PSYCH, V12, P323, DOI 10.1002/(SICI)1099-1166(199703)12:3<323::AID-GPS492>3.0.CO;2-N
  11. D'hooghe MB, 2016, ACTA NEUROL SCAND, V134, P414, DOI 10.1111/ane.12555
  12. Silva AM, 2015, MULT SCLER J, V21, P1312, DOI 10.1177/1352458515581874
  13. Feinstein A, 2013, J NEUROL, V260, P2256, DOI 10.1007/s00415-013-6952-9
  14. Fraga S, 2015, PREV MED, V71, P12, DOI 10.1016/j.ypmed.2014.11.031
  15. Fragoso YD, 2014, ARQ NEURO-PSIQUIAT, V72, P889, DOI 10.1590/0004-282X20140159
  16. Gold SM, 2003, J NEUROIMMUNOL, V138, P99, DOI 10.1016/S0165-5728(03)00121-8
  17. Greenaway MC, 2009, CLIN NEUROPSYCHOL, V23, P7, DOI 10.1080/13854040801891686
  18. Koster A, 2006, J GERONTOL A-BIOL, V61, P284, DOI 10.1093/gerona/61.3.284
  19. Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235
  20. Langdon DW, 2012, MULT SCLER J, V18, P891, DOI 10.1177/1352458511431076
  21. Lazeron RHC, 2005, MULT SCLER, V11, P524, DOI 10.1191/1352458505ms1201oa
  22. Lynch SG, 2005, MULT SCLER, V11, P469, DOI 10.1191/1352458505ms1182oa
  23. Miotto EC, 2012, ARQ NEURO-PSIQUIAT, V70, P962, DOI 10.1590/S0004-282X2012001200014
  24. Monteiro CA, 2001, J NUTR, V131, p881S
  25. Patti F, 2007, MULT SCLER, V13, P783, DOI 10.1177/1352458506073511
  26. Pinter D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087567
  27. Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032
  28. Schoonheim MM, 2014, HUM BRAIN MAPP, V35, P2348, DOI 10.1002/hbm.22332
  29. Schoonheim MM, 2012, NEUROLOGY, V79, P1754, DOI 10.1212/WNL.0b013e3182703f46
  30. Smith A., 1991, SYMBOL DIGIT MODALIT
  31. SNOWDON DA, 1989, AM J EPIDEMIOL, V130, P999, DOI 10.1093/oxfordjournals.aje.a115433
  32. SPREEN O., 1998, COMPENDIUM NEUROPSYC
  33. Stern Y, 2005, CEREB CORTEX, V15, P394, DOI 10.1093/cercor/bhh142
  34. Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248
  35. Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004
  36. Strauss E., 2006, COMPENDIUM NEUROPSYC
  37. Strober L, 2009, MULT SCLER, V15, P1077, DOI 10.1177/1352458509106615
  38. Sumowsk JF, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00176
  39. Sumowski JF, 2010, NEUROLOGY, V75, P1428, DOI 10.1212/WNL.0b013e3181f881a6
  40. Sumowski JF, 2016, MULT SCLER J, V22, P1621, DOI 10.1177/1352458516630822
  41. Sumowski JF, 2014, NEUROLOGY, V82, P1776, DOI 10.1212/WNL.0000000000000433
  42. Sumowski JF, 2010, NEUROLOGY, V74, P1942, DOI 10.1212/WNL.0b013e3181e396be
  43. Sumowski JF, 2010, BRAIN, V133, P362, DOI 10.1093/brain/awp307
  44. Sumowski JF, 2009, J INT NEUROPSYCH SOC, V15, P606, DOI 10.1017/S1355617709090912
  45. Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4
  46. Van Schependom J, 2014, EUR J NEUROL, V21, P1219, DOI 10.1111/ene.12463
  47. Wechsler D., 2014, WAIS 3 ESCALA INTELI
  48. Yeh EA, 2009, BRAIN, V132, P3392, DOI 10.1093/brain/awp278
  49. Zimmermann Nicolle, 2015, Dement. neuropsychol., V9, P120, DOI 10.1590/1980-57642015DN92000006

Coleções
Artigos e Materiais de Revistas Científicas - FM/MDR
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - LIM/21
Artigos e Materiais de Revistas Científicas - LIM/44
Artigos e Materiais de Revistas Científicas - LIM/45